'These test results are significant to the Company to the extent...

'These test results are significant to the Company to the extent that attention to development of selected patch products with suitable international partners can now
become more focused. It is the intention of OBJ to expedite securing commercial partners to embrace the use of OBJ’s patch technologies into the most appropriate applications.

OBJ Limited (ASX: OBJ) advises that it has now received the final report from Azopharma covering the Company’s research collaboration with a global Fast Moving Consumer Goods
(FMCG) company.

This are the key statements in the last announcement. The collaborative partner is a global consumer goods distributor. Their focus now is on attaining a commercial partner in developing the product commercially. May be a little while yet and that may be the reason the shareprice is going anywhere fast right now, however, this will be the next major announcement, and it will surely move the share price significntly higher.

Have to remember fully diluted this company currently has a marketcap of just $6mill. The exercised options alone have a value of $1.3mill meaning the market is currently valuing OBJs progress at just $4.7mill.

The more I think about it the more ridiculous it seems. As I speak .6c taken out. Volume has picked up a tad today.